Cargando…
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression
The Hippo signaling axis is a tumor suppressor pathway that is activated by various extra‐pathway factors to regulate cell differentiation and organ development. Recent studies have reported that autophosphorylation of the core kinase cassette stimulates activation of the Hippo signaling cascade. He...
Autores principales: | Sun, Yan, Jin, Xin, Meng, Junpeng, Guo, Feng, Chen, Taoyu, Zhao, Xiaoyan, Wu, Heshui, Ren, Dianyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690468/ https://www.ncbi.nlm.nih.gov/pubmed/37905571 http://dx.doi.org/10.15252/embj.2023114558 |
Ejemplares similares
-
USP22‐mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expression
por: Ren, Dianyun, et al.
Publicado: (2021) -
NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15
por: Guo, Feng, et al.
Publicado: (2021) -
MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker
por: Jin, Xiang, et al.
Publicado: (2021) -
The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
por: Zhang, Huan, et al.
Publicado: (2020) -
Structural basis of the heterodimerization of the MST and RASSF SARAH domains in the Hippo signalling pathway
por: Hwang, Eunha, et al.
Publicado: (2014)